Jonathan P Piccini Selected Research

Warfarin (Coumadin)

1/2022	Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
1/2021	Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale: From the COMBINE AF (A Collaboration between Multiple institutions to Better Investigate Non-vitamin K antagonist oral anticoagulant use in Atrial Fibrillation) Investigators.
1/2021	Rivaroxaban versus warfarin in patients with atrial fibrillation enrolled in Latin America: Insights from ROCKET AF.
10/2020	Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF).
1/2020	Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II Registry.
1/2020	Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
12/2019	Patient-Reported Satisfaction and Study Drug Discontinuation: Post-Hoc Analysis of Findings from ROCKET AF.
12/2019	Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
1/2019	Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II.
1/2019	Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan P Piccini Research Topics

Disease

210	Atrial Fibrillation 12/2022 - 06/2008
107	Stroke (Strokes) 08/2022 - 06/2008
73	Hemorrhage 08/2022 - 09/2011
63	Heart Failure 02/2022 - 03/2004
53	Embolism (Embolus) 01/2022 - 06/2008
19	Myocardial Infarction 01/2022 - 12/2008
16	Ventricular Tachycardia 01/2021 - 11/2005
12	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 10/2012
11	Ventricular Fibrillation 01/2019 - 11/2005
10	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2021 - 09/2011
10	Cardiac Sudden Death (Sudden Cardiac Arrest) 10/2018 - 11/2005
9	Hypertension (High Blood Pressure) 02/2022 - 09/2009
9	Transient Ischemic Attack 01/2022 - 09/2009
7	Chronic Renal Insufficiency 09/2021 - 08/2011
6	Infections 02/2022 - 11/2014
5	Tachycardia (Tachyarrhythmias) 01/2022 - 02/2011
5	Heart Diseases (Heart Disease) 01/2022 - 02/2015
5	Ischemic Stroke 01/2022 - 09/2011
5	Atrial Flutter (Flutter, Atrial) 12/2021 - 01/2016
5	Shock 01/2020 - 04/2011
5	Acute Coronary Syndrome 09/2016 - 06/2008
4	Cardiomyopathies (Cardiomyopathy) 02/2022 - 08/2008
4	Thrombosis (Thrombus) 01/2022 - 06/2008
4	Vascular Diseases (Vascular Disease) 01/2020 - 01/2018
4	Frailty 01/2019 - 07/2013
4	Chronic Obstructive Pulmonary Disease (COPD) 11/2018 - 03/2014
4	Anemia 12/2015 - 09/2009
3	Bacteremia 02/2022 - 01/2019
3	Fistula 08/2020 - 01/2017
3	Diabetes Mellitus 08/2020 - 07/2013
3	Mitral Valve Stenosis (Mitral Stenosis) 12/2017 - 12/2014
3	Venous Thromboembolism 03/2017 - 06/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2014 - 11/2013
2	Heart Arrest (Cardiac Arrest) 08/2022 - 01/2019
2	Bradycardia 02/2022 - 10/2018
2	Peripheral Arterial Disease 01/2022 - 01/2014
2	Left Ventricular Dysfunction 01/2022 - 03/2011
2	Cerebral Hemorrhage 01/2021 - 10/2015
2	Cardiac Arrhythmias (Arrythmia) 10/2020 - 01/2020
2	Hyperlipidemias (Hyperlipidemia) 01/2020 - 07/2013
2	Chronic Kidney Failure (Chronic Renal Failure) 12/2019 - 08/2015
2	Supraventricular Tachycardia 10/2019 - 03/2015
2	Fibrosis (Cirrhosis) 10/2019 - 04/2017
2	Neoplasms (Cancer) 01/2019 - 01/2017
2	Endocarditis 01/2019 - 06/2013
2	Cognitive Dysfunction 01/2019 - 12/2018
2	Obstructive Sleep Apnea 11/2018 - 05/2015
2	Thromboembolism 01/2018 - 10/2016
2	Carotid Artery Diseases 01/2018 - 01/2018
2	Death (Near-Death Experience) 01/2017 - 06/2015
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 03/2016 - 07/2013

Drug/Important Bio-Agent (IBA)

74	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 09/2009
54	RivaroxabanIBA 01/2022 - 06/2008
48	Vitamin K FDA Link 01/2022 - 05/2012
37	AnticoagulantsIBA 01/2022 - 07/2010
32	Factor Xa (Coagulation Factor Xa)IBA 01/2022 - 01/2013
24	Anti-Arrhythmia AgentsIBA 08/2022 - 07/2010
12	Pharmaceutical PreparationsIBA 01/2019 - 10/2012
11	N(4)-oleylcytosine arabinosideIBA 01/2021 - 01/2016
10	Factor Xa InhibitorsIBA 01/2022 - 07/2010
10	Amiodarone (Amiodarona)FDA LinkGeneric 01/2021 - 05/2009
10	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 04/2012
9	CreatinineIBA 01/2022 - 01/2013
7	apixabanIBA 01/2022 - 07/2010
6	bucindololIBA 02/2022 - 06/2015
6	Dronedarone FDA Link 01/2022 - 09/2009
5	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 01/2022 - 09/2014
5	Dabigatran FDA Link 11/2018 - 09/2013
4	Metoprolol (Toprol-XL)FDA LinkGeneric 02/2022 - 12/2017
3	N-methylvalineIBA 01/2022 - 01/2020
3	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 08/2008
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2015
3	Adenosine Triphosphate (ATP)IBA 01/2020 - 03/2015
3	Digoxin (Digitek)FDA LinkGeneric 11/2018 - 06/2015
2	dofetilide (Tikosyn)FDA Link 01/2022 - 06/2015
2	Insulin (Novolin)FDA Link 06/2021 - 01/2017
2	IceIBA 01/2020 - 12/2014
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 08/2017 - 09/2015
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 09/2016 - 01/2016

Therapy/Procedure

99	Therapeutics 08/2022 - 11/2005
56	Catheter Ablation 12/2022 - 12/2009
18	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 10/2018 - 11/2005
8	Cardiac Resynchronization Therapy 02/2022 - 04/2007
8	Electric Countershock (Cardioversion) 12/2021 - 05/2013
7	Drug Therapy (Chemotherapy) 08/2022 - 09/2012
7	Percutaneous Coronary Intervention 12/2021 - 09/2008
6	Defibrillators (Defibrillator) 02/2022 - 06/2013
6	Contraindications 01/2021 - 04/2014
4	Catheters 08/2020 - 01/2017
4	Device Removal (Removal, Device) 01/2019 - 11/2014
4	Secondary Prevention 03/2015 - 11/2005
3	Length of Stay 12/2022 - 01/2019
3	Patient Readmission 02/2022 - 04/2012
3	Drug Tapering 02/2022 - 01/2018
3	Radiofrequency Ablation 01/2021 - 09/2013
3	Heart-Assist Devices 07/2020 - 11/2014
3	Transcatheter Aortic Valve Replacement 12/2019 - 11/2012
2	Cryosurgery 08/2020 - 12/2011
2	Critical Care (Surgical Intensive Care) 04/2017 - 06/2013
2	Polypharmacy 07/2016 - 01/2016